Project Grant HT94252510694
Award Date
9/30/25
Completion Date
9/29/29
Dollars Obligated
$987K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
This $716,062 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research to dissect the dasatinib-ome and optimize therapy delivery to address cellular plasticity and therapy resistance in acral melanoma. The primary awardee is The Johns Hopkins University, a private non-profit research university. The university will collaborate with a sub-awardee, Northwestern University, to perform...
The Department of Defense's Defense Health Agency awarded a $900,625.00 Project Grant to The Johns Hopkins University on July 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant will fund research on "The Role of Organismal Aging and the Plantar Skin Microenvironment in Acral Melanoma Progression." This research aims to investigate how biological aging and the skin microbiome impact the progression of acral melanoma, a rare form of skin...
The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
This federal Project Grant award of $610,059.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Johns Hopkins University to investigate "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The award has a performance period from July 1, 2025 to June 30, 2028 and aims to transform healthcare for military service members, veterans, and the general public through innovative biomedical...
This Project Grant award of $1,972,922.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at "Therapeutic Targeting of TREM2-Positive Tumor-Associated Macrophages within the Tumor Microenvironment of Lethal Prostate Cancer to Reduce Health Disparities". The research will be conducted by The Johns Hopkins University, a leading private, non-profit research...
This federal Project Grant award, with a funding amount of $1,893,376.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant aims to "REVEAL SPATIAL TRANSCRIPTOMIC AND PROTEOMIC SHIFTS IN TUMOR-INFILTRATING IMMUNOCYTES: CHARTING A PATH TO ENHANCED MELANOMA THERAPEUTICS" and will be performed by the Jackson Laboratory, a non-profit biomedical research institution located in Bar Harbor, Maine. The grant's...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
The federal Project Grant award of $3,120,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by Thomas Jefferson University's Sidney Kimmel Medical College on novel tumor-targeted immunotherapies against metastatic uveal melanoma. This 4-year award, running from September 1, 2025 to August 31, 2029, aims to transform healthcare for military service members, veterans, and the broader public through innovative...
The Department of Defense's Defense Health Agency awarded a $318,483 Project Grant to The Johns Hopkins University under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used for a 2-year project to quantitatively measure acute and chronic lesion activity in a real-world, multi-site clinical MRI...